نتائج البحث

Efficacy and Safety of Low-Dose, Rapidly Infused Bamlanivimab and Etesevimab: Phase 3 BLAZE-1 Trial for Mild-to-Moderate COVID-19.

• Authors : Patel, Dipak R.¹ (AUTHOR); Macpherson, Lisa¹ (AUTHOR); Bohm, Martin¹ (AUTHOR)

• Source: Infectious Diseases & Therapy. Oct2024, Vol. 13 Issue 10, p2123-2134. 12p.

تفاصيل العنوان

Efficacy and Safety of Low-Dose, Rapidly Infused Bamlanivimab and Etesevimab: Phase 3 BLAZE-1 Trial for Mild-to-Moderate COVID-19

• Authors : Dipak R. Patel; Lisa Macpherson; Martin Bohm

Subjects: Bamlanivimab; BLAZE-1; Clinical trial

• Source: Infectious Diseases and Therapy, Vol 13, Iss 10, Pp 2123-2134 (2024)

تفاصيل العنوان

Long COVID After Bamlanivimab Treatment

• Authors : Evering, Teresa H; Moser, Carlee B; Jilg, Nikolaus

Subjects: Biomedical and Clinical Sciences; Clinical Sciences; Prevention

• Source: The Journal of Infectious Diseases. 228(Supplement_2)

تفاصيل العنوان

Expanded Access Program to Provide Bamlanivimab (LY3819253) for the Treatment of COVID-19

• Authors : AbCellera Biologics Inc.

• Source: Expanded Access Information for Physicians for Bamlanivimab (LY3819253) Emergency Investigational New Drug [EIND]Kreuzberger N, Hirsch C, Chai KL, Tomlinson E,

تفاصيل العنوان

Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab or Sotrovimab on Persistently High Viral Load in Patients with Mild-to-Moderate COVID-19: A Randomized, Phase 2 BLAZE-4 Trial

• Authors : Russell M. Nichols; Lisa Macpherson; Dipak R. Patel

Subjects: Bamlanivimab; Etesevimab; mAb

• Source: Infectious Diseases and Therapy, Vol 13, Iss 2, Pp 401-411 (2024)

تفاصيل العنوان

Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab or Sotrovimab on Persistently High Viral Load in Patients with Mild-to-Moderate COVID-19: A Randomized, Phase 2 BLAZE-4 Trial.

• Authors : Nichols, Russell M.¹ (AUTHOR) ; Macpherson, Lisa¹ (AUTHOR); Patel, Dipak R.¹ (AUTHOR)

• Source: Infectious Diseases & Therapy. Feb2024, Vol. 13 Issue 2, p401-411. 11p.

تفاصيل العنوان

Bamlanivimab Reduces ED Returns and Hospitalizations and May Reduce COVID-19 Burden on Low-resource Border Hospitals

• Authors : Quenzer, Faith C.; Lafree, Andrew T.; Grey, Londyn

Subjects: monoclonal antibody; bamlanivimab; SARS-CoV-2

• Source: Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health. 23(3)

تفاصيل العنوان

At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19 (UNITED)

• Authors : Eli Lilly and Company; Optum, Inc.; Daniel Griffin, Daniel Griffin, MD PhD CTropMed CTH

• Source: At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M,

تفاصيل العنوان

SARS-CoV-2 neutralizing antibody therapies: an early retrospective cohort study of 26 hospitalized patients treated with bamlanivimab or casirivimab/imdevimab

• Authors : Martin Heller; Clara Henrici; Judith Büttner

Subjects: COVID-19; Bamlanivimab; Casirivimab

• Source: International Journal of Infectious Diseases, Vol 129, Iss , Pp 260-265 (2023)

تفاصيل العنوان

Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses

• Authors : Ramirez, Sydney I; Grifoni, Alba; Weiskopf, Daniela

Subjects: Biomedical and Clinical Sciences; Immunology; Vaccine Related

• Source: JCI Insight. 7(24)

تفاصيل العنوان